Import Biopunch — Buy in Bulk from Supplier in India

The Biopunch from S.P.Enterprise is a disposable medical instrument engineered for dermatological biopsy procedures and aural cerumen removal, supplied in bulk packaging of 100 units per case with two individual pieces per inner box for controlled dispensing. Each unit is supplied non-sterile, permitting end-user facilities to apply their preferred sterilization protocol, whether gamma irradiation, ethylene oxide, or autoclave, depending on institutional standards and the specific material grade of the punch body. The instrument is fabricated from surgical-grade stainless steel, a material selected for its resistance to corrosion, maintenance of cutting-edge integrity through repeated use cycles, and compatibility with standard sterilization modalities.

The typical biopsy punch architecture comprises a cylindrical cutting cannula with a bevelled distal edge and an integrated plunger mechanism for specimen ejection, though buyers should confirm with S.P.Enterprise whether this specific model employs a manual plunger, thumb-press, or gravity-assisted ejection system. Wall thickness of the cannula, measured in millimetres, determines the structural rigidity during tissue penetration and correlates with the force required for sample acquisition; standard dermatology punches range from 1 mm to 8 mm in diameter, with 4 mm and 6 mm representing the most frequently requested sizes for diagnostic skin biopsies. The ergonomic handle referenced in the source description typically features a textured grip surface and balanced weight distribution to reduce hand fatigue during serial procedures, though the exact handle geometry and material (polypropylene, ABS, or coated metal) should be verified directly with the supplier.

Primary end-users include hospital dermatology departments, outpatient clinic networks, veterinary surgical practices, and academic research facilities conducting histological or immunohistochemical studies on dermal tissue samples. The non-sterile presentation suits facilities with in-house sterilization infrastructure, while the 100-unit bulk case aligns with high-throughput environments where instrument consumption justifies volume procurement. Buyers should confirm with S.P.Enterprise the available diameter options, whether single-use disposability is absolute or re-sterilization is feasible, and whether the product carries any notified-body certification for EU market access or US FDA 510(k) clearance, as these regulatory attributes are not stated in the available source data.

S.P.Enterprise operates from 52/22 S.B.N.G. Lane, Kolkata 700036, West Bengal, India, positioning the company within one of India's established medical device manufacturing and distribution clusters with access to both domestic raw material supply chains and export logistics infrastructure through Kolkata Port and Netaji Subhas Chandra Bose International Airport. The supplier is classified under an imported tier with a harbor trust designation, and the source data records a response rate of 0.00 percent with zero average response hours, indicating that prospective buyers should anticipate delayed or potentially absent communication through standard inquiry channels and may need to pursue alternative contact methods or engage through established trade intermediaries.

The supplier profile does not disclose manufacturing facility scale, workforce size, annual revenue, client roster, or years in operation, nor does it specify whether S.P.Enterprise functions as a manufacturer, distributor, or trading house for the Biopunch product line. The available description references ISO and CE certifications without identifying the certifying body, scope, or validity period, and buyers should independently verify these claims through certificate number lookup with the relevant notified bodies. The Kolkata address suggests proximity to regional medical device trade networks, though this geographic concentration does not in itself confer quality assurance, and due diligence on production standards, batch traceability, and post-market surveillance capacity remains the responsibility of the importing party.